University of Colorado Researchers Launch First Evidence-Based Decision Tool for Parkinson’s Deep Brain Stimulation Patients

A new evidence-based tool from CU Anschutz helps Parkinson's patients weigh the risks and benefits of deep brain stimulation with personalized symptom reports.

By: AXL Media

Published: Mar 17, 2026, 4:29 AM EDT

Source: Information for this report was sourced from University of Colorado Anschutz

Bridging the Knowledge Gap in Neurological Surgical Interventions

The transition from pharmaceutical management to surgical intervention represents one of the most daunting phases for individuals living with Parkinson's disease. Deep brain stimulation, or DBS, remains a premier treatment for motor symptoms, yet its technical complexity often leaves patients paralyzed by decisional conflict. To mitigate this, a research team at the University of Colorado Anschutz developed an evidence-based framework to transform how patients evaluate the procedure. According to Michelle Fullard, MD, the Director of Clinical Research at the CU Anschutz Movement Disorders Center, the initiative shifts the focus from simple information sharing to genuine shared decision-making between the clinician and the patient.

Rigorous Development Through Patient Centered Research Cycles

The creation of this decision aid followed a strict protocol to ensure the final product resonated with the actual needs of the Parkinson's community. The research team engaged over 120 participants across three distinct developmental phases, starting with a comprehensive needs assessment involving 57 patients. Following this, a prototype was refined through direct clinical testing before a final group of 46 individuals evaluated the tool for its accessibility and quality. This iterative process allowed the researchers to target specific areas where patients felt most uninformed, such as the surgical process itself and the long-term management of the implanted battery-powered devices.

Statistical Validation of Patient Satisfaction and Tool Efficacy

Data published in the Journal of Parkinson's Disease suggests that the new digital resource has been overwhelmingly well-received by those navigating the DBS evaluation process. Metrics from the study indicate that 91 percent of users found the language easy to follow, while 87 percent expressed high satisfaction with the overall quality of the decision aid. Most significantly, 94 percent of participants stated they would recommend the tool to others facing similar medical crossroads. These figures underscore a clear demand for structured, plain-language guidance that can be accessed independently before high-stakes specialist consultations.